Pooled Wk 48 Analysis of Switch to BIC/FTC/TAF in Virologically Suppressed Patients Aged 65 Yrs or Older

July 6-10, 2020; Virtual
Analysis of data from 4 international trials of switching to BIC/FTC/TAF found high rate of efficacy and favorable tolerability in older virologically suppressed patients.
Format: Microsoft PowerPoint (.ppt)
File Size: 210 KB
Released: July 11, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences
ViiV Healthcare
Merck Sharp & Dohme Corp.

Related Content

Clinical Care Options (CCO) commentary from Dr Darrell Tan on the dosing options for long-acting injectable cabotegravir plus rilpivirine for HIV treatment

Babafemi Taiwo, MBBS
Program Director
Darrell H. S. Tan, MD, FRCPC, PhD
Released: August 12, 2022

Clinical Care Options (CCO) expert Carolyn Chu, MD, MSc, discusses how to improve HIV pre-exposure prophylaxis accessibility and availability for PWID

person default Carolyn Chu, MD, MSc, FAAFP, AAHIVS Released: August 12, 2022

Drs. Jean Rene Anderson and William Short speak to the balancing act when considering HIV treatments during pregnancy, from Clinical Care Options (CCO)

Jean Rene Anderson, MD William R. Short, MD, MPH, AAHIVS Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: August 12, 2022 Expired: August 11, 2023

Understand medical, social, and emotional challenges faced by older PWH, from Clinical Care Options (CCO)

Jonathan Appelbaum, MD, FACP, AAHIVS
Program Director
Melanie Reese
Program Director
Lydia Mungherera, MBChB Cristina Mussini, MD Dorothy Onyango Marc Thompson
Released: August 9, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings